Establishment of a Trans-round Window Inner Ear Continuous Drug Delivery System for the Treatment of Severe-to-profound Sudden Sensorineural Hearing Loss
Not Applicable
- Conditions
- Hearing Loss, Sudden
- Interventions
- Procedure: Surgical treatment of round window niche enlargement via round window for inner ear drug deliveryProcedure: Drum chamber drug injection
- First Posted Date
- 2022-07-13
- Last Posted Date
- 2022-07-13
- Target Recruit Count
- 218
- Registration Number
- NCT05455398
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients
Not Applicable
- Conditions
- Malignant Fungating Wound
- Interventions
- Procedure: malignant fungating wounds care regimen
- First Posted Date
- 2022-07-13
- Last Posted Date
- 2022-07-13
- Target Recruit Count
- 50
- Registration Number
- NCT05457309
- Locations
- 🇨🇳
Sun Yat-sen memorial hospital, Sun Yat-sen university, Guangzhou, Guangdong, China
A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPC
Not Applicable
- Conditions
- Otitis Media With Effusion After Nasopharyngeal Carcinoma
- Interventions
- Procedure: Balloon Eustachian Tuboplasty with Tympanostomy Tube InsertionProcedure: Tympanostomy Tube Insertion
- First Posted Date
- 2022-07-08
- Last Posted Date
- 2022-07-08
- Target Recruit Count
- 208
- Registration Number
- NCT05449184
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical Study
Phase 4
Recruiting
- Conditions
- Temporal Bone Squamous Cell Carcinoma
- Interventions
- Drug: Paprizumab combined with cisplatin and 5-FU
- First Posted Date
- 2022-07-06
- Last Posted Date
- 2022-07-06
- Target Recruit Count
- 30
- Registration Number
- NCT05444673
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
First-line Olaparib Combined With Bevacizumab Maintenance Therapy
- Conditions
- Ovarian Neoplasms
- Interventions
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2022-07-01
- Target Recruit Count
- 50
- Registration Number
- NCT05440578
TCR-T Cell Therapy on Advanced Pancreatic Cancer
Early Phase 1
Recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- Biological: TCR-T therapy
- First Posted Date
- 2022-06-30
- Last Posted Date
- 2023-07-18
- Target Recruit Count
- 18
- Registration Number
- NCT05438667
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
Not Applicable
Recruiting
- Conditions
- Head and Neck Squamous Cell CarcinomaSentinel Lymph Node
- Interventions
- Diagnostic Test: peritumoral microbubbles and contrast-enhanced ultrasonography
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 70
- Registration Number
- NCT05437380
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
Phase 2
Recruiting
- Conditions
- Perihilar Cholangiocarcinoma
- Interventions
- Drug: PD-1antibody plus GEMOX
- First Posted Date
- 2022-06-24
- Last Posted Date
- 2023-05-09
- Target Recruit Count
- 62
- Registration Number
- NCT05430698
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus
Not Applicable
Not yet recruiting
- Conditions
- Vagus Nerve StimulationFemaleMusic TherapyTinnitus, SubjectiveHumansMaleTreatment OutcomeDouble-Blind Method
- Interventions
- Device: Transcutaneous Vagus Nerve Stimulation Paired with Tailor-Made Notched Music TherapyDevice: Tailor-made Notched Music Training
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2023-11-27
- Target Recruit Count
- 388
- Registration Number
- NCT05417711
mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC
Phase 2
Recruiting
- Conditions
- Stage III Hepatocellular Cancer (CNLC Staging)
- Interventions
- Drug: mFOLFOX7+Camrelizumab+Apatinib
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2024-07-31
- Target Recruit Count
- 35
- Registration Number
- NCT05412589
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath